Delcath Systems, Inc. (NASDAQ: DCTH) (the "Company"), an interventional oncology company focused on treatments for primary and metastatic liver cancers ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE